Can patients with pulmonary fibrosis inhale birch tree sap vapor?

Generally, patients with pulmonary fibrosis are not advised to inhale birch sap vapor arbitrarily, as it has no proven therapeutic effect and may pose risks. In case of concerns, it is recommended to prioritize standardized treatments. The detailed explanation is as follows:

Birch sap vapor is not a clinically recognized treatment method. Its components have not been proven to improve the condition of pulmonary fibrosis or alleviate core symptoms such as shortness of breath and declining lung function. Blind inhalation is unlikely to achieve the desired effects.

The respiratory mucosa in patients with pulmonary fibrosis is sensitive and fragile. Birch sap vapor may contain unknown irritants that could trigger airway spasms, worsen coughing, or even induce infections, further damaging lung function. Moreover, such vapors lack uniform safety standards, and their purity cannot be guaranteed, posing potential health risks.

Patients with pulmonary fibrosis should receive standardized treatment under professional guidance and must not rely on folk remedies or unproven methods. If considering any new complementary approach, consult your doctor in advance to evaluate its safety. Take daily precautions to protect the respiratory tract by avoiding exposure to unknown gases, dust, and other irritants. Regularly undergo lung function tests and adjust treatment plans according to disease progression.